Label: CLINIQUE TARGETED PROTECTION SPF 45 BROAD SPECTRUM SUNSCREEN- homosalate, octisalate, and avobenzone stick
- NDC Code(s): 49527-041-01
- Packager: CLINIQUE LABORATORIES LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated July 28, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients
- Purpose
- Use
- Warnings
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- reapply at least every two hours
- use a water resistant sunscreen if swimming or sweating
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeved shirts, pants, hats and sunglasses
- children under 6 months of age: ask a doctor
-
Inactive ingredients
microcrystalline wax\cera microcristallina\cire microcristalline • jojoba esters • phenyl trimethicone • simmondsia chinensis (jojoba) butter • cetyl ricinoleate • butyloctyl salicylate • polyester-8 • beeswax\cera alba\cire d'abeille • polyethylene • tocopheryl acetate • vp/eicosene copolymer • tocopherol [iln35001]
- Other information
- PRINCIPAL DISPLAY PANEL - 6 g Cylinder Carton
-
INGREDIENTS AND APPEARANCE
CLINIQUE TARGETED PROTECTION SPF 45 BROAD SPECTRUM SUNSCREEN
homosalate, octisalate, and avobenzone stickProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49527-041 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 5 g in 100 g OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 5 g in 100 g AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 3 g in 100 g Inactive Ingredients Ingredient Name Strength MICROCRYSTALLINE WAX (UNII: XOF597Q3KY) PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R) JOJOBA BUTTER (UNII: XIA46H803R) CETYL RICINOLEATE (UNII: 1P677500YD) BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3) YELLOW WAX (UNII: 2ZA36H0S2V) HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) TOCOPHEROL (UNII: R0ZB2556P8) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49527-041-01 1 in 1 CARTON 12/01/2008 1 6 g in 1 CYLINDER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final M020 12/01/2008 Labeler - CLINIQUE LABORATORIES LLC (044475127) Registrant - Estee Lauder Companies Inc. (790802086) Establishment Name Address ID/FEI Business Operations Estee Lauder Cosmetics Ltd. 202952982 manufacture(49527-041) Establishment Name Address ID/FEI Business Operations Estee Lauder Cosmetics Ltd. 204132062 pack(49527-041) , label(49527-041)